Search results
Halozyme Therapeutics (HALO) Up 8.7% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 19 hours agoPerformance of an Industry Player Halozyme Therapeutics belongs to the Zacks Medical - Biomedical...
Moderna's RSV Vaccine Approved by FDA
Medscape· 4 days agoFor the first time, an mRNA vaccine has been approved for an indication other than COVID-19. The vaccine will join a couple other immunizations currently on the market for respiratory syncytial virus.
Merck, Moderna Drug Combo Shows Improved Survival in Skin Cancer Trial
Morningstar· 4 days agoModerna and Merck said they saw positive results from a Phase 2b study evaluating mRNA-4157 in combination with Keytruda in patients with high-risk skin cancer that was surgically ...
COVID vaccine makers ready updated shots for fall immunization drive (NYSE:PFE)
Seeking Alpha· 2 days agoPfizer (PFE), BioNTech (BNTX), Moderna (MRNA) and Novavax (NVAX) reaffirm commitment to provide...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
KRCG· 21 hours agoGovernment advisers Wednesday said it's time to update the recipe for the COVID-19 vaccines...
Moderna wins second product approval with RSV vaccine
Morningstar· 7 days agoModerna Inc.'s respiratory syncytial virus vaccine for older adults received U.S. regulatory approval, the company said Friday, marking the first time a messenger RNA vaccine ...
Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R)...
Digital Journal· 4 days agoAt a median planned follow-up of the Phase 2b study at 34.9 months, mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 49% and the risk of distant metastasis ...
Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine
Benzinga· 7 days agoOn Friday, the FDA approved Moderna Inc’s MRNA mRESVIA (mRNA-1345), an mRNA respiratory syncytial virus (RSV) vaccine to protect adults aged 60 and older from lower respiratory ...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
Associated Press via Yahoo News· 2 days agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
San Francisco Chronicle· 1 day agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...